Abstract
BackgroundPD-L1 expression by immunohistochemistry (IHC) is associated with HNSCC immunotherapy response.1 The performance of different PD-L1 IHC clones has shown variability and poor concordance for immune vs. tumor cell scoring...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
